Cadema Corp said it entered aletter of intent with a national underwriting firm for anoffering of five mln dlrs worth of convertible preferred stock.    Cadema said it will file a registration statement with theSecurities and Exchange Commission later this month for theoffering. Proceeds will be used to fund clinical trials for thecompany's treatments for rheumatoid arthritis and metastaticbone cancer.    It also said it increased the size of its board to six fromfive members. Reuter&#3;